3rd Quarter - Report

AMEDISYS, INC. for AMEDISYS, INC.

Firm
Client
Income
—
Expenses
$410,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to Centers for Medicare and Medicaid policies, including the CY 2023 Home Health Prospective Payment System Rate Update, FY 2023 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Requirement, H.R. 2471, Consolidated Appropriations Act of 2022, S. 3792/H.R. 7053, Hospital In-Patient Modernization Act of 2022, Monitoring progress of Build Back Better legislation, S. 4605/H.R. 8581, Preserving Access to Home Health Act of 2022; Issues related to hospice cap

LobbyistCovered position, as disclosed
DAVE KEMMERLY —
SCOTT M. LEVY —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 3792 (117th), H.R. 2471 (117th), H.R. 7053 (117th), H.R. 8581 (117th), S. 4605 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.